OSA phenotyping: is there value in guiding future therapies?

This keynote presentation by David White from Sleep DownUnder 2018 looks at OSA phenotyping and its potential value in developing future therapies.

 Chairperson: Brad Edwards



ASA Member – Free
Non-Member - 40.00AUD

To view the full session recording, click Add to Cart below, then check out your cart to finalise your order. You will need to be logged in with your member details, or create an account on this website, to complete your order.

OSA phenotyping: is there value in guiding future therapies?

This keynote address by David White from Sleep DownUnder 2018 explores the clinical value of phenotyping in the management of OSA.
40.00